Salipro Biotech & Bicycle Therapeutics collaboration

Written By Jens Frauenfeld

Salipro Biotech and Bicycle Therapeutics jointly announce results from their collaboration on a wild-type GPCR drug target. Results have just been published in Frontiers in Bioengineering and Biotechnology: “DirectMX – One-Step Reconstitution of Membrane Proteins From Crude Cell Membranes Into Salipro Nanoparticles”.

Publication reference:
P. Lloris-Garcerá, et al., DirectMX – One-Step Reconstitution of Membrane Proteins From Crude Cell Membranes Into Salipro Nanoparticles. Front. Bioeng. Biotechnol. 8, 1–9 (2020).

Jens Frauenfeld
Previous

Muscle protein structure solved using Salipro and snake venom
Next

Salipro Biotech pitches at SwedenBIO's Shark Tank event